ATOVIB F 10/160ATORVASTATIN CALCIUM 10mg. IP + FENOFIBRATE 160mg. IP

Atovib F 10/160 tablets combine atorvastatin and fenofibrate to help manage raised cholesterol and triglycerides in adults. Main uses: adjunct to diet in adults with primary hypercholesterolemia; lowers elevated LDL cholesterol, total cholesterol, triglycerides and apolipoprotein B; raises HDL cholesterol in adults with mixed dyslipidemia; treatment of severe hypertriglyceridemia in adults; lowers LDL cholesterol in adults with heterozygous familial hypercholesterolemia.

Common side effects of Atovib F 10/160 Tablet include nasopharyngitis; arthralgia; diarrhoea; pain in extremity; urinary tract infection; myalgia. Get medical help at once if you notice myopathy and rhabdomyolysis; the risk is higher when a statin and fenofibrate are taken together, especially in older adults and in people with diabetes, kidney failure or hypothyroidism; serious drug-induced liver injury; gallbladder stones (cholelithiasis).

Each Atovib F 10/160 tablet contains Atorvastatin Calcium 10 mg + Fenofibrate 160 mg. The right dose and how long to take it depend on the condition, age and other medicines, so use Atovib F 10/160 Tablet only as your doctor advises.

The MRP of Atovib F 10/160 Tablet is ₹208.13 for a pack of 10x10 (Alu Alu). For chemists and distributors, the PTR is ₹158.58 and the PTS is ₹142.72.

Each Atovib F 10/160 tablet contains Atorvastatin Calcium 10 mg + Fenofibrate 160 mg. It comes in a pack of 10x10 (Alu Alu).

Atorvastatin Calcium slows the liver's own production of cholesterol and helps the liver remove more LDL cholesterol from the blood. Fenofibrate works on the PPAR-alpha pathway to speed the breakdown and removal of triglyceride-rich particles. Together they lower LDL cholesterol, total cholesterol and triglycerides and raise HDL cholesterol. Because a statin and fenofibrate are given together, the risk of myopathy and rhabdomyolysis is higher, especially in older adults and in people with diabetes, kidney failure or hypothyroidism.

Must not be used in patients with acute liver failure or decompensated cirrhosis. Must not be used in patients with active liver disease, including persistent unexplained liver-function abnormalities. Must not be used in patients with severe kidney impairment, including those on dialysis. Must not be used in patients with gallbladder disease. Must not be used by nursing mothers.

Atovib F 10/160 Tablet is a brand of Vibcare Pharma, sold through its Cure division. It is available for PCD pharma franchise and distribution in India; use the Send Enquiry or WhatsApp button on this page to ask about availability and terms.